Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0461929603
Mon, 27.05.2024
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Alliance/Merger
Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH
27.05.2024 / 07:00 CET/CEST
Zurich, 27th of May 2024: Xlife Sciences AG announces the merger of its portfolio company, palleos healthcare GmbH, with OCT Clinical GmbH. This [ … ]
Mon, 05.02.2024
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Alliance/Letter of Intent
Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City
05.02.2024 / 07:00 CET/CEST
Xlife Sciences AG is excited to announce the expansion of its existing collaboration with the Departme [ … ]
Fri, 22.12.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Research Update/Study
Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases
22.12.2023 / 07:00 CET/CEST
Xlife Sciences AG is pleased to announce that its project company, x-nuclear diagnostics GmbH, has reached a decisive milestone in [ … ]
Wed, 20.12.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Letter of Intent/Partnership
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases
20.12.2023 / 07:00 CET/CEST
Xlife Sciences AG (SIX: XLS) and Quant Biomarke [ … ]
Fri, 29.09.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Sustainability/ESG
ESG Report shows status quo and outlines path for future sustainability improvements
Media Release
Zurich, September 29, 2023
29.09.2023 / 07:00 CET/CEST
Xlife Sciences (SIX: XLS) today published its inaugural report on Environmental, Social and Governance ( [ … ]
Tue, 20.06.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): AGMEGM
Media Release
Zurich, June 20, 2023
Xlife Sciences: shareholders approved all motions at today’s AGM 2023
20.06.2023 / 17:00 CET/CEST
Xlife Sciences AG (SIX: XLS) announces that its shareholders approved all motions on the agenda of the Ordinary Annual General Meeting (AGM) 2023 that [ … ]
Tue, 20.06.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): AGMEGM
Media Release
Zurich, June 20, 2023
Xlife Sciences: shareholders approved all motions at today’s AGM 2023
20.06.2023 / 17:00 CET/CEST
Xlife Sciences AG (SIX: XLS) announces that its shareholders approved all motions on the agenda of the Ordinary Annual General Meeting (AGM) 2023 that [ … ]
Mon, 23.01.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Stifel initiates research coverage of Xlife Sciences
23.01.2023 / 07:00 CET/CEST
The renowned investment bank Stifel commenced its research coverage of Xife Sciences (SIX: XLS). The corresponding initial analyst report rates Xlife Sciences' stock with a “Buy” rating and calls for [ … ]
Fri, 20.01.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Patent
Xlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent OfficeTitle
20.01.2023 / 07:00 CET/CEST
Xlife Sciences AG (SIX: XLS) announced today that its Swiss portfolio company Axenoll Life Sciences AG has been granted a strategically si [ … ]
Mon, 16.01.2023
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Xlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS)
16.01.2023 / 07:00 CET/CEST
Xlife Sciences' (SIX: XLS) portfolio company inflamed pharma has launched a research project to develop a potential therapy for amyotr [ … ]